NATCO Pharma Limited at its board meeting held on August 09, 2023, declared interim dividend of INR 7/(350%) per equity share of INR 2/- each for the financial year 2023-24. The date for taking on record of its shareholders eligible for the purpose of payment of interim dividend i.e., record date is fixed as the 22nd day of August 2023. The payment of said interim dividend will start from 30th August 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
990 INR | +1.59% | -0.50% | +22.01% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.01% | 2.09B | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- NATCO Pharma Limited Declares Interim Dividend for the Financial Year 2023-24